Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $37 | $38 | $35 | $37 |
| - Cash | $13 | $14 | $14 | $14 |
| + Debt | $32 | $32 | $32 | $30 |
| Enterprise Value | $57 | $56 | $53 | $53 |
| Revenue | $10 | $9 | $10 | $10 |
| % Growth | 7.2% | -7.2% | -2.8% | – |
| Gross Profit | $5 | $5 | $5 | $5 |
| % Margin | 48.5% | 47.8% | 46.1% | 48.1% |
| EBITDA | $2 | $2 | $1 | $2 |
| % Margin | 16.8% | 17.8% | 14.4% | 17.4% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 9.3% | 8.1% | 7.5% | 7.5% |
| EPS Diluted | 0.35 | 0.29 | 0.29 | 0.3 |
| % Growth | 20.7% | 0% | -3.3% | – |
| Operating Cash Flow | $1 | $1 | $0 | $2 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |